10 webinars results for

long-term gene expression.

Join us on April 22ⁿᵈ for an exclusive webinar on Cell and Gene Therapy (CGT) development!

Whereas, viral vectors can serve as vehicles to deliver therapeutic genes to treat monogenic disorders

products are one of the most common non-viral vectors, frequently used in both in vivo and ex vivo gene

Director of Platform R&D Department, manages the platform R&D department to develop antibody, protein, and gene

screening for both IgG and VHH antibody, and HTP cell-to-antibody conversion system without sequencing or gene

delivery and extensive understanding of drug development to help you get your own success. 14 weeks from gene

Pre-clinical through clinical to commercial supply, ProBio is marching forward to support more cell and gene

platform process R&D department to develop process R&D platforms based on antibodies, proteins, and gene

Li was an R&D Manager in MilliporeSigma (USA), leading the development of the company’s Gene Therapy